QSAR models for phosphoramidate prodrugs of 2'-methylcytidine as inhibitors of hepatitis C virus based on PSO boosting

Chemical Biology and Drug Design

Volumn 78, Issue 6, 2011, Pages 948-959

  Cheng, Zhengjun ^a   Zhang, Yuntao ^a   Zhou, Changhong ^a  

^a CHINA WEST NORMAL UNIVERSITY   (China)

Author keywords

Boosting regression; Hepatitis C virus; Phosphoramidate prodrugs of 2' methylcytidine; Quantitative structure activity relationship; Support vector machine

Indexed keywords

2' METHYLCYTIDINE PHOSPHORAMIDATE DERIVATIVE; ANTIVIRUS AGENT; PRODRUG; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALGORITHMS; AMIDES; ANTIVIRAL AGENTS; CYTIDINE; HEPACIVIRUS; NEURAL NETWORKS (COMPUTER); PHOSPHORIC ACIDS; PRODRUGS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT VECTOR MACHINES;

HEPATITIS C VIRUS;

EID: 81355132236     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01236.x     Document Type: Article

References (45)

1. Meppen M., Pacini B., Bazzo R., Koch U., Leone J.F., Koeplinger K.A., Rowley M. et al. (2009) Cyclic phosphoramidates as prodrugs of 2-C-methylcytidine. Eur J Med Chem;44:3765-3770.
2. Shepard C.W., Finelli L., Alter M.J. (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis;5:558-567.
3. Hughes C.A., Shafran S.D. (2006) Treatment of hepatitis C in HIV-coinfected patients. Ann Pharmacother;40:479-489.
4. Pierra C., Amador A., Benzaria S., Cretton-Scott E., Amours M.D., Mao J., Mathieu S., Moussa A., Bridges E.G., Standring D.N., Sommadossi J.P., Storer R., Gosselin G. (2006) Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2-C-methylcytidine. J Med Chem;49:6614-6620.
5. Hecker S.J., Reddy K.R., van Poelje P.D., Sun Z.L., Huang W.J., Varkhedkar V., Reddy M.V., Fujitaki J.M., Olsen D.B., Koeplinger K.A., Boyer S.H., Linemeyer D.L., MacCoss M., Erion M.D. (2007) Liver-targeted prodrugs of 2-C-methyladenosine for therapy of hepatitis C virus infection. J Med Chem;50:3891-3896.
6. Stankiewicz-Drogon A., Palchykovska L.G., Kostina V.G., Alexeeva I.V., Shved A.D., Boguszewska-Chachulska A.M. (2008) New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection. Bioorgan Med Chem;16:8846-8852.
7. McGuigan C., Perrone P., Madela K., Neyts J. (2009) The phosphoramidate ProTide approach greatly enhances the activity of β-2-C-methylguanosine against hepatitis C virus. Bioorg Med Chem Lett;19:4316-4320.
8. Deng Y.Q., Shipps G.W. Jr, Wang T., Popovici-Muller J., Rosner K.E., Siddiqui M.A., Duca J., Cooper A.B., Cable M. (2009) Discovery of 4H-pyrazolo[1, 5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase. Bioorg Med Chem Lett;19:5363-5367.
9. Gardelli C., Attenni B., Donghi M., Meppen M., Pacini B., Harper S., Marco A.D. et al. (2009) Phosphoramidate prodrugs of 2-C-methylcytidine for therapy of hepatitis C virus infection. J Med Chem;52:5394-5407.
10. Donghi M., Attenni B., Gardelli C., Marco A.D., Fiore F., Giuliano C., Laufer R., Leone J.F., Pucci V., Rowley M., Narjes F. (2009) Synthesis and evaluation of novel phosphoramidate prodrugs of 2-methyl cytidine as inhibitors of hepatitis c virus NS5B polymerase. Bioorg Med Chem Lett;19:1392-1395.
11. Laszlo T. (2010) Monte Carlo method for identification of outlier molecules in QSAR studies. J Math Chem;47:174-190.
12. Deeb O., Goodarzi M. (2010) Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM. Chem Biol Drug Des;75:506-514.
13. Doytchinova I.A., Walshe V., Borrow P., Flower D.R. (2005) Towards the chemometric dissection of peptide - HLA-A*0201 binding affinity: comparison of local and global QSAR models. J Comput Aid Mol;15:203-212.
14. Cheng Z.J., Zhang Y.T., Zhang W.J. (2010) QSAR studies of imidazopyridine derivatives as Et-PKG inhibitors by using PSO-SVM approach. Med Chem Res;19:1307-1325.
15. Xu Q.S., Daszykowski M., Walczak B., Daeyaert F., de Jonge M.R., Heeres J., Koymans L.M.H., Lewi P.J., Vinkers H.M., Janssen P.A., Massart D.L. (2004) Multivariate adaptive regression splines-studies of HIV reverse transcriptase inhibitors. Chemometr Intell Lab;72:27-34.
16. Sun M., Chen J.Q., Cai J., Cao M., Yin S.Q., Ji M. (2010) Simultaneously optimized support vector regression combined with genetic algorithm for QSAR analysis of KDR/VEGFR-2 inhibitors. Chem Biol Drug Des;75:494-505.
17. Schapire R.E. (1990) The strength of weak learnability. Mach Learn;5:197-227.
18. Zhang M.H., Xu Q.S., Massart D.L. (2005) Boosting partial least squares. Anal Chem;77:1423-1431.
19. Zhou Y.P., Cai C.B., Huan S., Jiang J.H., Wu H.L., Shen G.L., Yu R.Q. (2007) QSAR study of angiotensin II antagonists using robust boosting partial least squares regression. Anal Chim Acta;593:68-74.
20. Cao D.S., Xu Q.S., Liang Y.Z., Zhang L.X., Li H.D. (2010) The boosting: a new idea of building models. Chemometr Intell Lab;100:1-11.
21. Panek J.J., Jezierska A., Vračko M.J. (2005) Kohonen network study of aromatic compounds based on electronic and nonelectronic structure descriptors. Chem Inf Model;45:264-272.
22. Papa E., Luini M., Gramatica P. (2009) Quantitative structure-activity relationship modelling of oral acute toxicity and cytotoxic activity of fragrance materials in rodents. SAR QSAR Environ Res;20:767-779.
23. Cheng Z.J., Zhang Y.T., Zhou C.H., Zhang W.J., Gao S.B. (2009) Classification of 5-HT1A receptor ligands on the basis of their binding affinities by using PSO-Adaboost-SVM. Int J Mol Sci;10:3316-3337.
24. Martinez J.C.G., Duchowicz P.R., Estrada M.R., Zamarbide G.N., Castro E. (2009) Anticonvulsant activity of ringed enaminones: a QSAR study. QSAR Comb Sci;28:1376-1385.
25. Kennedy J., Eberhard R.C. (1995) Particle swarm optimization. In: Proceedings of IEEE International Conference on Neural Networks. Piscataway, NJ, USA, p. 1942-1948.
26. Kennedy J., Eberhart R.C. (2001) Swarm Intelligence. San Francisco: Morgan Kaufmann Publishers.
27. Pan Q.K., Tasgetiren M.F., Liang Y.C. (2008) A discrete particle swarm optimization algorithm for the no-wait flowshop scheduling problem. Comput Oper Res;35:2807-2839.
28. Shi Y.H., Eberhart R. (1998) Modified particle swarm optimizer. In: Proceedings of IEEE International Conference on Evolutionary Computation, Anchorage, Alaska, p. 69-73.
29. Mandal K.K., Basu M., Chakraborty N. (2008) Particle swarm optimization technique based short-term hydrothermal scheduling. Appl Soft Comput;8:1392-1399.
30. Schapire R.E., Singer Y. (1999) Improved boosting algorithms using confidence-rated predictions. Mach Learn;37:297-336.
31. Freund Y., Schapire R.E. (1997) A decision-theoretic generalization of on-line learning and an application to boosting. J Comput System Sci;55:119-139.
32. Bauer E., Kohavi R. (1999) An empirical comparison of voting classification algorithms: bagging, boosting, and variants. Mach Learn;36:105-139.
33. Dietterich T.G. (2000) An experimental comparison of three methods for constructing ensembles of decision trees: bagging, boosting, and randomization. Mach Learn;40:139-157.
34. Friedman J.H., Hastie T., Tibshirani R. (2000) Additive logistic regression: a statistical view of boosting. Ann Stat;28:337-407.
35. Zemel R.S., Pitassi T. (2001) A gradient-based boosting algorithm for regression problems. In: Advances in Neural Information Processing Systems, no.13 in NIPS-13, p. 696-702.
36. Duffy N., Helmbold D. (2000) Leveraging for regression. In: Proceedings of COLT. San Francisco: Morgan Kaufmann, p. 208-219.
37. Friedman J.H. (2001) Greedy function approximation: a gradient boosting machine. Ann Stat;29:1189-1232.
38. Karakoulas G., Shawe-Taylor J. (2000) Towards a strategy for boosting regressors. In: Smola A. J., Bartlett P. L., Schölkopf B., and Schuurmans D., editors. Advances in Large Margin Classifiers. Cambridge, MA: MIT Press; p. 247-258.
39. Rätsch G., Warmuth M., Mika S., Onoda T., Lemm S., Müller K.R. (2000) Barrier boosting, Proceedings of the Thirteenth Annual Conference on Computational Learning Theory. San Francisco, CA, USA: Morgan Kaufmann Publishers Inc.; p. 170-179.
40. Cortes C., Vapnik V. (1995) Support-vector networks. Mach Learn;20:273-297.
41. Liu H.X., Zhang R.S., Yao X.J., Liu M.C., Hu Z.D., Fan B.T. (2004) QSAR and classification models of a novel series of COX-2 selective inhibitors: 1, 5-diarylimidazoles based on support vector machines. J Comput Aid Mol Des;18:389-399.
42. Goodarzi M., Freitas M.P. (2008) Augmented three-mode MIA-QSAR modeling for a series of anti-HIV-1 compounds. QSAR Comb Sci;27:1092-1098.
43. Akaike H. (1974) A new look at the statistical model identification. IEEE Trans Automat Contr AC-19:716-723.
44. Kubinyi H. (1994) Variable selection in QSAR studies. I. An evolutionary algorithm. Quant Struct Act Relat;13:285-294.
45. Kubinyi H. (1994) Variable selection in QSAR studies. II. A highly efficient combination of systematic search and evolution. Quant Struct Act Relat;13:393-401.